The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Open accessAbstract
Cancer testis antigens (CTA) are a large family of tumor‐associated antigens expressed in human tumors of different histological origin, but not in normal tissues except for testis and placenta. This tumor‐restricted pattern of expression, together with their strong in vivo immunogenicity, identified CTA as ideal targets for tumor‐specific immunotherapeutic approaches, and prompted the development of several clinical trials of CTA‐based vaccine therapy. Driven by this practical clinical interest, a more detailed characterization of CTA biology has been recently undertaken. So far, at least 70 families of CTA, globally accounting for about 140 members, have been identified. Most of these CTA are expressed during spermatogenesis, but their function is still largely unknown. Epigenetic events, particularly DNA methylation, appear to be the primary mechanism regulating CTA expression in both normal and transformed cells, as well as in cancer stem cells. In view of the growing interest in CTA biology, the aim of this review is to provide the most recent information on their expression, regulation and function, together with a brief summary of the major clinical trials involving CTA as therapeutic agents. The pharmacologic modulation of CTA expression profiles on neoplastic cells by DNA hypomethylating drugs will also be discussed as a feasible approach to design new combination therapies potentially able to improve the clinical efficacy of currently adopted CTA‐based immunotherapeutic regimens in cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., José‐Eneriz, E. S., Gárate, L., Cordeu, L., Cervantes, F., Prósper, F., et al. (2007) · Haematologica · doi:10.3324/haematol.10782 · Cited by 58
RetractedA Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 26×
“Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.”
BackgroundInfluentialMolecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Cancer/testis antigens, gametogenesis and cancer
Simpson, A. J. G., Caballero, O. L., Jungbluth, A., Chen, Y.-T., & Old, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1669 · Cited by 1,582
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.-P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-10 · Cited by 1,280
Tachibana, M., Sugimoto, K., Nozaki, M., Ueda, J., Ohta, T., Ohki, M., Fukuda, M., Takeda, N., Niida, H., Kato, H., et al. (2002) · Genes & Development · doi:10.1101/gad.989402 · Cited by 1,253
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1669 · Cited by 1,226
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Morse, M. A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T. M., Valente, N., Shreeniwas, R., Sutton, M. A., Delcayre, A., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-9 · Cited by 1,120
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
Scanlan., M. J., Gure., A. O., Jungbluth., A. A., Old., L. J., & Chen., Y. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18803.x · Cited by 873
Tachibana, M., Ueda, J., Fukuda, M., Takeda, N., Ohta, T., Iwanari, H., Sakihama, T., Kodama, T., Hamakubo, T., & Shinkai, Y. (2005) · Genes & Development · doi:10.1101/gad.1284005 · Cited by 845
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
Banchereau, J., Palucka, A. K., Dhodapkar, M. V., Burkeholder, S. B., Taquet, N., Rolland, A., Taquet, S., Coquery, S., Wittkowski, K. M., Bhardwaj, N., et al. (2001) · PubMed · Cited by 806
Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dr�no, B., Tessier, M.-H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s · Cited by 784
Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., & Boon, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.921 · Cited by 762
Koivisto, P. A., Kononen, J., Palmberg, C., Tammela, T. L. J., HYYTINEN, E.-R., Isola, J. J., Trapman, J., Cleutjens, K. B. J. M., Noordzij, M. A., Visakorpi, T., et al. (1997) · PubMed · Cited by 728
Jäger, E., Chen, Y.-T., Drijfhout, J. W., Karbach, J., Ringhoffer, M., Jäger, D., Arand, M., Wada, H., Noguchi, Y., Stockert, E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.265 · Cited by 725
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
Stockert, E., Jäger, E., Chen, Y.-T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., & Old, L. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1349 · Cited by 698
The cancer/testis genes: review, standardization, and commentary.
Scanlan, M. J., Simpson, A. J. G., & Old, L. J. (2004) · PubMed · Cited by 667
Immunostimulatory monoclonal antibodies for cancer therapy
Melero, I., Hervas-Stubbs, S., Glennie, M., Pardoll, D. M., & Chen, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2051 · Cited by 627
Krüppel-associated boxes are potent transcriptional repression domains.
Margolin, J. F., Friedman, J. R., Meyer, W. K., Vissing, H., Thiesen, H. J., & Rauscher, F. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4509 · Cited by 618
De Smet, C., Lurquin, C., Lethé, B., Martelange, V., & Boon, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7327 · Cited by 598
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
De Plaen, E., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Chomez, P., et al. (1994) · Immunogenetics · doi:10.1007/bf01246677 · Cited by 586
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., & van der Bruggen, P. (1995) · Immunity · doi:10.1016/s1074-7613(95)80053-0 · Cited by 583
An overview of the MAGE gene family with the identification of all human members of the family.
Chomez, P., Backer, O. D., Bertrand, M. J. M., Plaen, E. D., Boon, T., & Lucas, S. (2001) · PubMed · Cited by 573
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., & Boon, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.689 · Cited by 567
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Caballero, O. L., & Chen, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01303.x · Cited by 554
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Crew, A. J., Clark, J., Fisher, C., Gill, S., Grimer, R., Chand, A., Shipley, J., Gusterson, B. A., & Cooper, C. S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07228.x · Cited by 474
New Paths in Human Cancer Serology
Old, L. J., & Chen, Y.-T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1163 · Cited by 446
Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403572101 · Cited by 440
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Almeida, L. G., Sakabe, N. J., deOliveira, A. R., Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y.-T., Chua, R., Gurung, S., Gnjatic, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 433
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413497 · Cited by 426
NY‐ESO‐1: Review of an Immunogenic Tumor Antigen
(2006) · Advances in Cancer Research · doi:10.1016/s0065-230x(06)95001-5 · Cited by 405
Epidermal stem cells: markers, patterning and the control of stem cell fate
Watt, F. M. (1998) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1998.0247 · Cited by 400
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Jäger, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jäger, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4760 · Cited by 398
Tumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
Loukinov, D. I., Pugacheva, E., Vatolin, S., Pack, S. D., Moon, H., Chernukhin, I., Mannan, P., Larsson, E., Kanduri, C., Vostrov, A. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092123699 · Cited by 377
Jonuleit, H., Giesecke-Tuettenberg, A., T�ting, T., Thurner-Schuler, B., Stuge, T. B., Paragnik, L., Kandemir, A., Lee, P. P., Schuler, G., Knop, J., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1323 · Cited by 375
Gure, A. O., Chua, R., Williamson, B., Gonen, M., Ferrera, C. A., Gnjatic, S., Ritter, G., Simpson, A. J. G., Chen, Y.-T., Old, L. J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1203 · Cited by 357
Yuan, J., Gnjatic, S., Li, H., Powel, S., Gallardo, H. F., Ritter, E., Ku, G. Y., Jungbluth, A. A., Segal, N. H., Rasalan, T. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810114105 · Cited by 348
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
Jungbluth, A. A., Chen, Y.-T., Stockert, E., Busam, K. J., Kolb, D., Iversen, K., Coplan, K., Williamson, B., Altorki, N., & Old, L. J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1282 · Cited by 347
Mackensen, A., Herbst, B., Chen, J.-L., K�hler, G., Noppen, C., Herr, W., Spagnoli, G. C., Cerundolo, V., & Lindemann, A. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t · Cited by 345
Chromatin modifier enzymes, the histone code and cancer
Santos-Rosa, H., & Caldas, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.010 · Cited by 337
Serological identification of human tumor antigens
Sahin, U., Türeci, Ö., & Pfreundschuh, M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80053-2 · Cited by 315
Functional consequences of histone modifications
Iizuka, M., & Smith, M. M. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00020-0 · Cited by 310
Higashitsuji, H., Itoh, K., Nagao, T., Dawson, S., Nonoguchi, K., Kido, T., Mayer, R. J., Arii, S., & Fujita, J. (2000) · Nature Medicine · doi:10.1038/71600 · Cited by 299
Valmori, D., Souleimanian, N. E., Tosello, V., Bhardwaj, N., Adams, S., O'Neill, D., Pavlick, A., Escalon, J. B., Cruz, C. M., Angiulli, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703395104 · Cited by 299
Weber, J. S., Salgaller, M. L., Samid, D., Johnson, B., Herlyn, M., Lassam, N. J., Treisman, J. S., & Rosenberg, S. A. (1994) · PubMed · Cited by 294
Expression of MAGE genes in primary and metastatic cutaneous melanoma
Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630313 · Cited by 285
Odunsi, K., Qian, F., Matsuzaki, J., Mhawech-Fauceglia, P., Andrews, C., Hoffman, E. W., Pan, L., Ritter, G., Villella, J., Thomas, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703342104 · Cited by 270
Reactivating the expression of methylation silenced genes in human cancer
Karpf, A. R., & Jones, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205602 · Cited by 264
Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., & Schneider, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510834103 · Cited by 257
Cancer/testis‐associated genes: Identification, expression profile, and putative function
Zendman, A. J. W., Ruiter, D. J., & Van Muijen, G. N. P. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10215 · Cited by 255
Odunsi, K. O., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A. F., Keitz, B. T., Santiago, D., et al. (2003) · PubMed · Cited by 249
Zhou, S., Fujimuro, M., Hsieh, J. J.-D., Chen, L., Miyamoto, A., Weinmaster, G., & Hayward, S. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2400-2410.2000 · Cited by 245
SSX: A multigene family with several members transcribed in normal testis and human cancer
Gure, A. O., Türeci, Ö., Şahin, U., Tsang, S., Scanlan, M. J., Jäger, E., Knuth, A. K., Pfreundschuh, M. G., Old, L. J., & Chen, Y. (1997) · International Journal of Cancer · Cited by 239
Schrump, D. S., Fischette, M. R., Nguyen, D. M., Zhao, M., Li, X., Kunst, T. F., Hancox, A., Hong, J. A., Chen, G. A., Pishchik, V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0669 · Cited by 227
CpG islands as genomic footprints of promoters that are associated with replication origins
Antequera, F., & Bird, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80418-7 · Cited by 224
Sigalotti, L., Fratta, E., Coral, S., Tanzarella, S., Danielli, R., Colizzi, F., Fonsatti, E., Traversari, C., Altomonte, M., & Maio, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1442 · Cited by 217
Self-citationJäger, E., Karbach, J., Gnjatic, S., Neumann, A., Bender, A., Valmori, D., Ayyoub, M., Ritter, E., Ritter, G., Jäger, D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606512103 · Cited by 216
Lucas, S., Smet, C. D., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C., & Boon, T. (1998) · PubMed · Cited by 210
HER-2, gp100, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells
Liu, G., Ying, H., Zeng, G., Wheeler, C. J., Black, K. L., & Yu, J. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3504 · Cited by 198
Vatolin, S., Abdullaev, Z., Pack, S. D., Flanagan, P. T., Custer, M., Loukinov, D. I., Pugacheva, E., Hong, J. A., Morse, H., Schrump, D. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0858 · Cited by 198
Methyl CpG binding proteins: coupling chromatin architecture to gene regulation
Wade, P. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204340 · Cited by 198
Hong, J. A., Kang, Y., Abdullaev, Z., Flanagan, P. T., Pack, S. D., Fischette, M. R., Adnani, M. T., Loukinov, D. I., Vatolin, S., Risinger, J. I., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0823 · Cited by 197
Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., et al. (2001) · PubMed · Cited by 193
De Smet, C., Loriot, A., & Boon, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4781-4790.2004 · Cited by 192
Wischnewski, F., Pantel, K., & Schwarzenbach, H. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0229 · Cited by 185
Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients
Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3289 · Cited by 184
An oncological view on the blood–testis barrier
Bart, J., Groen, H. J., van der Graaf, W. T., Hollema, H., Hendrikse, N. H., Vaalburg, W., Sleijfer, D. T., & de Vries, E. G. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00776-3 · Cited by 183
Scanlan, M. J., Gout, I. T., Gordon, C., Williamson, B., Stockert, E., Gure, A. O., Jäger, D., Chen, Y., Mackay, A. G., O'Hare, M. J., et al. (2001) · PubMed · Cited by 182
Jungbluth, A. A., Ely, S., DiLiberto, M., Niesvizky, R., Williamson, B., Frosina, D., Chen, Y.-T., Bhardwaj, N., Chen-Kiang, S., Old, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4931 · Cited by 182
Tyagi, P., & Mirakhur, B. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.052 · Cited by 174
van Baren, N., Bonnet, M.-C., Dréno, B., Khammari, A., Dorval, T., Piperno-Neumann, S., Liénard, D., Speiser, D., Marchand, M., Brichard, V. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.375 · Cited by 173
Cloning, Characterization, and Localization of Mouse and Human SPO11
Romanienko, P. J., & Camerini‐Otero, R. D. (1999) · Genomics · doi:10.1006/geno.1999.5955 · Cited by 171
Marchand, M., Punt, C. J. A., Aamdal, S., Escudier, B., Kruit, W. H. J., Keilholz, U., Håkansson, L., van Baren, N., Humblet, Y., Mulders, P., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00479-3 · Cited by 169
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
Backer, O. D., Arden, K. C., Boretti, M., Vantomme, V., Smet, C. D., Czekay, S., Viars, C. S., Plaen, E. D., Brasseur, F., Chomez, P., et al. (1999) · PubMed · Cited by 167
Slingluff, C. L., Petroni, G. R., Chianese-Bullock, K. A., Smolkin, M. E., Hibbitts, S., Murphy, C., Johansen, N., Grosh, W. W., Yamshchikov, G. V., Neese, P. Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0486 · Cited by 163
Weiser, T. S., Guo, Z. S., Ohnmacht, G. A., Parkhurst, M. L., Tong-On, P., Marincola, F. M., Fischette, M. R., Yu, X., Chen, G. A., Hong, J. A., et al. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00010 · Cited by 162
Brichard, V. G., & Lejeune, D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.038 · Cited by 160
Kruit, W. H. J., van Ojik, H. H., Brichard, V. G., Escudier, B. J., Dorval, T., Dréno, B., Patel, P. M., van Baren, N., Avril, M., Piperno‐Neumann, S., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21264 · Cited by 160
Atanackovic, D., Altorki, N. K., Cao, Y., Ritter, E., Ferrara, C. A., Ritter, G., Hoffman, E. W., Bokemeyer, C., Old, L. J., & Gnjatic, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707140104 · Cited by 158
Thaete, C., Brett, D., Monaghan, P., Whitehouse, S. K., Rennie, G. R., Rayner, E. L., Cooper, C. S., & Goodwin, G. H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.585 · Cited by 157
Bai, S., He, B., & Wilson, E. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1238-1257.2005 · Cited by 151
Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos, N. R., Torensma, R., de Vries, T. J., Schreurs, M. W. J., de Bruijn, D. R. H., Kater‐Baats, E., Ruiter, D. J., Adema, G. J., van Muijen, G. N. P., & van Kessel, A. G. (2000) · PubMed · Cited by 150
Brett, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1559 · Cited by 144
Sigalotti, L., Fratta, E., Coral, S., Cortini, E., Covre, A., Nicolay, H. J. M., Anzalone, L., Pezzani, L., Giacomo, A. M. D., Fonsatti, E., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21066 · Cited by 144
Self-citationCoral, S., Sigalotti, L., Altomonte, M., Engelsberg, A., Colizzi, F., Cattarossi, I., Maraskovsky, E., Jäger, E., Seliger, B., & Maio, M. (2002) · PubMed · Cited by 143
Self-citationScanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 140
Lim, F.-L., Soulez, M., Koczan, D., Thiesen, H., & Knight, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202122 · Cited by 140
Lurquin, C., Smet, C. D., Brasseur, F., Muscatelli, F., Martelange, V., Plaen, E. D., Brasseur, R., Monaco, A. P., & Boon, T. (1997) · Genomics · doi:10.1006/geno.1997.5052 · Cited by 139
Guo, Z. S., Hong, J. A., Irvine, K. R., Chen, G. A., Spiess, P. J., Liu, Y., Zeng, G., Wunderlich, J. R., Nguyen, D. M., Restifo, N. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3020 · Cited by 138
Fonsatti, E., Nicolay, H. J. M., Sigalotti, L., Calabrò, L., Pezzani, L., Colizzi, F., Altomonte, M., Guidoboni, M., Marincola, F. M., & Maio, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3091 · Cited by 135
Self-citationOverexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.
Duan, Z., Duan, Y., Lamendola, D. E., Yusuf, R. Z., Naeem, R., Penson, R. T., & Seiden, M. V. (2003) · PubMed · Cited by 134
Expression of cancer/testis (CT) antigens in lung cancer
Tajima, K., Obata, Y., Tamaki, H., Yoshida, M., Chen, Y., Scanlan, M. J., Old, L. J., Kuwano, H., Takahashi, T., Takahashi, T., et al. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00244-7 · Cited by 131
MAGE-A gene expression pattern in primary breast cancer.
Otte, M., Zafrakas, Μ., Riethdorf, L., et al. (2001) · PubMed · Cited by 131
Banchereau, J., Ueno, H., Dhodapkar, M. V., Connolly, J., Finholt, J. P., Klechevsky, E., Blanck, J.-P., Johnston, D. A., Palucka, K., & Fay, J. W. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000171292.79663.cb · Cited by 130
Coral, S., Sigalotti, L., Gasparollo, A., Cattarossi, I., Visintin, A., Cattelan, A., Altomonte, M., & Maio, M. (1999) · Journal of Immunotherapy · doi:10.1097/00002371-199901000-00003 · Cited by 127
Self-citationKarpf, A. R., Bai, S., James, S. R., Mohler, J. L., & Wilson, E. M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0400 · Cited by 126
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.
Koslowski, M., Türeci, Ö., Bell, C., Krause, P., Lehr, H., Brunner, J., Seitz, G., Nestle, F. O., Huber, C., & Şahin, U. (2002) · PubMed · Cited by 124
Lucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 122
Identification on a human sarcoma of two new genes with tumor-specific expression.
Martelange, V., Smet, C. D., Plaen, E. D., Lurquin, C., & Boon, T. (2000) · PubMed · Cited by 120
Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
Andrade, V. C. C., Vettore, A. L., Felix, R. S., Almeida, M. S. S., de Carvalho, F., de Oliveira, J. S. R., Chauffaille, M. D. L. L. F., Andriolo, A., Caballero, O. L., Zago, M. A., et al. (2008) · PubMed Central · Cited by 120
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma
Hersey, P., Menzies, S. W., Halliday, G. M., Nguyen, T., Farrelly, M. L., Desilva, C., & Lett, M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0429-0 · Cited by 119
Nicholaou, T., Ebert, L. M., Davis, I. D., McArthur, G. A., Jackson, H. M., Dimopoulos, N., Tan, B. S., Maraskovsky, E., Miloradovic, L., Hopkins, W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2484 · Cited by 119
Expression of cancer testis genes in human brain tumors.
Şahin, U., Koslowski, M., Türeci, Ö., Eberle, T., Zwick, C., Romeike, B. F. M., Moringlane, J. R., Schwechheimer, K., Feiden, W., & Pfreundschuh, M. G. (2000) · PubMed · Cited by 115
Identification and Characterization of a Novel Cancer/Testis Antigen Gene CAGE
Cho, B., Lim, Y., Lee, D.-Y., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6701 · Cited by 115
Promoter Methylation Controls the Expression of MAGE2, 3 and 4 Genes in Human Cutaneous Melanoma
Sigalotti, L., Coral, S., Nardi, G., Spessotto, A., Cortini, E., Cattarossi, I., Colizzi, F., Altomonte, M., & Maio, M. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200201000-00002 · Cited by 114
Self-citationSmith, I. M., Glazer, C. A., Mithani, S. K., Ochs, M. F., Sun, W., Bhan, S., Vostrov, A. A., Abdullaev, Z., Lobanenkov, V. V., Gray, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004961 · Cited by 113
Cancer/testis antigens and gametogenesis: a review and "brain-storming" session.
Kalējs, M., & Erenpreisa, J. A. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-4 · Cited by 111
Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., & Murai, M. (2001) · PubMed · Cited by 110
MAGE-A4 Interacts with the Liver Oncoprotein Gankyrin and Suppresses Its Tumorigenic Activity
Nagao, T., Higashitsuji, H., Nonoguchi, K., Sakurai, T., Dawson, S. P., Mayer, R. J., Itoh, K., & Fujita, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206104200 · Cited by 108
Adair, S. J., & Hogan, K. T. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0582-6 · Cited by 108
Isolation and characterization of a MAGE gene family in the Xp21.3 region.
Muscatelli, F., Walker, A. P., Plaen, E. D., Stafford, A., & Monaco, A. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4987 · Cited by 103
Shigematsu, Y., Hanagiri, T., Shiota, H., Kuroda, K., Baba, T., Mizukami, M., So, T., Ichiki, Y., Yasuda, M., So, T., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.05.010 · Cited by 102
Karpf, A. R. (2006) · Epigenetics · doi:10.4161/epi.1.3.2988 · Cited by 99
Li, M., Yuan, Y., Yan, H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1365 · Cited by 99
Lucas, S., Plaen, E. D., & Boon, T. (2000) · International Journal of Cancer · Cited by 96
Nguyen, P., Bar‐Sela, G., Sun, L., Bisht, K. S., Cui, H., Kohn, E. C., Feinberg, A. P., & Gius, D. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00568-08 · Cited by 95
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene
Smet, C. D., Courtois-Cox, S., Faraoni, I., Lurquin, C., Szikora, J., Backer, O. D., & Boon, T. (1995) · Immunogenetics · doi:10.1007/bf00176446 · Cited by 94
Cancer-Testis Antigens: Expression and Correlation with Survival in Human Urothelial Carcinoma
Sharma, P., Shen, Y., Wen, S., Bajorin, D. F., Reuter, V. E., Old, L. J., & Jungbluth, A. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0527 · Cited by 92
Brinkmann, U., Vasmatzis, G., Lee, B., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10757 · Cited by 90
Demethylation of MAGE promoters during gastric cancer progression
Honda, T., Tamura, G., Waki, T., Kawata, S., Terashima, M., Nishizuka, S., & Motoyama, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601600 · Cited by 89
Sigalotti, L., Coral, S., Altomonte, M., Natali, L., Gaudino, G., Cacciotti, P., Libener, R., Colizzi, F., Vianale, G., Martini, F., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600174 · Cited by 88
Self-citationYoshida, N., Abé, H., Ohkuri, T., Wakita, D., Satō, M., Noguchi, D., Miyamoto, M., Morikawa, T., Kondo, S., Ikeda, H., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1089 · Cited by 86
The Melanoma Antigen Genes—Any Clues to Their Functions in Normal Tissues?
Forslund, K. Ö., & Nordqvist, K. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5173 · Cited by 83
Isolation and Characterization of PAGE-1 andGAGE-7
Chen, M. E., Lin, S.-H., Chung, L. W. K., & Sikes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17618 · Cited by 80
Cuffel, C., Rivals, J., Zaugg, Y., Salvi, S., Seelentag, W. K. F., Speiser, D. E., Líénard, D., Monnier, P., Romero, P. J., Bron, L. P., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25607 · Cited by 80
Induction of MAGE-3 expression in lung and esophageal cancer cells
Weiser, T. S., Ohnmacht, G. A., Guo, Z. S., Fischette, M. R., Chen, G. A., Hong, J. A., Nguyen, D. M., & Schrump, D. S. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02421-8 · Cited by 80
Sigalotti, L., Altomonte, M., Colizzi, F., Degan, M., Rupolo, M., Zagonel, V., Pinto, A., Gattei, V., & Maio, M. (2003) · Blood · doi:10.1182/blood-2002-11-3458 · Cited by 79
Self-citationXAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.
Liu, X. F., Helman, L. J., Yeung, C., Bera, T. K., Lee, B., & Pastan, I. H. (2000) · PubMed · Cited by 78
Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
Atanackovic, D., Luetkens, T., Hildebrandt, Y., Arfsten, J., Bartels, K., Horn, C., Stahl, T., Cao, Y., Zander, A. R., Bokemeyer, C., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0989 · Cited by 77
Expression of MAGE Genes in Human Colorectal Carcinoma
Mori, M., Inoue, H., Mimori, K., Shibuta, K., 馬場, 欽., Nakashima, H., Haraguchi, M., Tsuji, K., Ueo, H., Barnard, G. F., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199608000-00011 · Cited by 77
Zendman, A. J. W., van Kraats, A. A., Weidle, U. H., Ruiter, D. J., & van Muijen, G. N. P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10371 · Cited by 77
Major Histocompatibility Complex Expression on Human, Male Germ Cells: A Review
Fiszer, D., & Kurpisz, M. K. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00409.x · Cited by 74
Epigenetic targets for immune intervention in human malignancies
Maio, M., Coral, S., Fratta, E., Altomonte, M., & Sigalotti, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206956 · Cited by 71
Self-citationEpigenetic regulation of PRAME gene in chronic myeloid leukemia
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., José‐Eneriz, E. S., Gárate, L., Cordeu, L., Cervantes, F., Prósper, F., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.02.016 · Cited by 70
Palucka, A. K., Dhodapkar, M. V., Paczesny, S., Burkeholder, S. B., Wittkowski, K. M., Steinman, R. M., Fay, J. W., & Banchereau, J. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200309000-00006 · Cited by 69
Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
Sun, F., Chan, E., Wu, Z., Yang, X., Márquez, V. E., & Yu, Q. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0479 · Cited by 69
An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members
Gjerstorff, M. F., & Ditzel, H. J. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00997.x · Cited by 66
Maio, M., Coral, S., Sigalotti, L., Elisei, R., Romei, C., Rossi, G., Cortini, E., Colizzi, F., Fenzi, G., Altomonte, M., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020830 · Cited by 65
Self-citationThe clinical significance of MAGEA3 expression in pancreatic cancer
Kim, J. M., Reber, H. A., Hines, O. J., Kazanjian, K. K., Tran, A. N., Ye, X., Amersi, F. F., Martinez, S. R., Dry, S., Bilchik, A. J., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21656 · Cited by 64
Sigalotti, L., Covre, A., Zabierowski, S. E., Himes, B. T., Colizzi, F., Natali, P. G., Herlyn, M., & Maio, M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21380 · Cited by 64
Self-citationde Bruijn, D. R. H., dos Santos, N. R., Kater‐Baats, E., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10073 · Cited by 64
Kobayashi, Y., Higashi, T., Nouso, K., Nakatsukasa, H., Ishizaki, M., Kaneyoshi, T., Toshikuni, N., Kariyama, K., Nakayama, E., & Tsuji, T. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80223-8 · Cited by 63
Link, P. A., Gangisetty, O., James, S. R., Woloszynska‐Read, A., Tachibana, M., Shinkai, Y., & Karpf, A. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0497 · Cited by 59
Louahed, J., Gruselle, O., Gaulis, S., Coche, T. G., Eggermont, A. M. M., Kruit, W., Dréno, B., Chiarion‐Sileni, V., Lehmann, F., & Brichard, V. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.9045 · Cited by 59
Expressions of cancer-testis antigens in human hepatocellular carcinomas
Chen, C., Chen, G.-J., Lee, M., Huang, G., Yang, P., Tsai, L.-J., Chen, D., & Sheu, J. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00379-2 · Cited by 58
Cancer-testis (CT) antigen expression in medulloblastoma
Oba‐Shinjo, S. M., Caballero, O. L., Jungbluth, A. A., Rosemberg, S., Old, L. J., Simpson, A. J. G., & Marie, S. K. N. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.13140/rg.2.2.16107.57126 · Cited by 56
Taylor, B. J., Reiman, T., Pittman, J. A., Keats, J. J., de Bruijn, D. R. H., Mant, M. J., Belch, A. R., & Pilarski, L. M. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175685.36239.e5 · Cited by 56
Bender, A., Karbach, J., Neumann, A., Jäger, D., Al-Batran, S. E., Atmaca, A., Weidmann, E., Biskamp, M., Gnjatic, S., Pan, L. S., et al. (2007) · PubMed Central · Cited by 52
MAGE-A3 is a frequent tumor antigen of metastasized melanoma
Roeder, C., Schuler‐Thurner, B., Berchtold, S., Vieth, G., Driesch, P. V. D., Schuler, G., & L�ftl, M. (2004) · Archives of Dermatological Research · doi:10.1007/s00403-004-0527-7 · Cited by 50
Akiyama, Y., Tanosaki, R., Inoue, N., 島田, 真., 保立幸恵, Yamamoto, A., Yamazaki, N., Kawashima, I., Nukaya, I., Takesako, K., et al. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-4 · Cited by 48
Coral, S., Sigalotti, L., Colizzi, F., Spessotto, A., Nardi, G., Cortini, E., Pezzani, L., Fratta, E., Fonsatti, E., Giacomo, A. M. D., et al. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20540 · Cited by 48
Self-citationExpression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines
Zhang, S., Xiaoliang, Z., Yu, H., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-163 · Cited by 48
Ruault, M., van der Bruggen, P., Brun, M.-E., Boyle, S., Roizès, G., & Sario, A. D. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200891 · Cited by 48
Türeci, Ö., Şahin, U., Koslowski, M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205481 · Cited by 48
Targeting the Epigenome for the Treatment and Prevention of Lung Cancer
Schrump, D. S., & Nguyen, D. M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.007 · Cited by 44
Valmori, D., Qian, F., Ayyoub, M., Renner, C., Merlo, A. C., Gnjatic, S., Stockert, E., Driscoll, D., Lele, S., Old, L. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1902 · Cited by 37
Kular, R. K., Yehiely, F., Kumar, K. U., Cilensek, Z. M., Bedi, R., & Deiss, L. P. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0099 · Cited by 31
Quantitative expression and immunogenicity of MAGE‐3 and ‐6 in upper aerodigestive tract cancer
Filho, P. A. A., López‐Albaitero, A., Xi, L., Gooding, W. E., Godfrey, T. E., & Ferris, R. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24590 · Cited by 30
5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story
Coral, S., Sigalotti, L., Covre, A., Nicolay, H. J. M., Natali, P. G., & Maio, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2986 · Cited by 23
Self-citationEpigenetically regulated clonal heritability of CTA expression profiles in human melanoma
Fratta, E., Sigalotti, L., Colizzi, F., Covre, A., Nicolay, H. J. M., Danielli, R., Fonsatti, E., Altomonte, M., Calabrò, L., Coral, S., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22040 · Cited by 21
Self-citationSato, S., Noguchi, Y., Wada, H., Fujita, S., Nakamura, S., Tanaka, R., Nakada, T., Hasegawa, K., Nakagawa, K., Koizumi, F., et al. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.1.57 · Cited by 13
Cited by
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Passaro, A., Al Bakir, M., Hamilton, E. G., Diehn, M., André, F., Roy-Chowdhuri, S., Mountzios, G., Wistuba, I. I., Swanton, C., & Peters, S. (2024) · Cell · doi:10.1016/j.cell.2024.02.041 · Cited by 672
The emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Thomas, R., Al-Khadairi, G., Roelands, J., Hendrickx, W., Dermime, S., Bedognetti, D., & Decock, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00947 · Cited by 393
CD8+ T cell exhaustion and cancer immunotherapy
Wang, Q., Qin, Y., & Li, B. (2023) · Cancer Letters · doi:10.1016/j.canlet.2022.216043 · Cited by 155
Challenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer
Samuel, S. M., Varghese, E., Varghese, S., & Büsselberg, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.004 · Cited by 141
Metadata
- Authors
- Fratta, E., Coral, S., Covre, A., Parisi, G., Colizzi, F., Danielli, R., Marie Nicolay, H. J., Sigalotti, L., & Maio, M.
- Venue
- Molecular Oncology
- Publisher
- Wiley
- Published
- 2011-02-18
- Volume
- 5
- Issue
- 2
- Pages
- 164-182
- ISSN
- 1574-7891 (ISSN-L)
- 1878-0261
- OpenAlex
- W2165263439
- Cited by
- 375
- References
- 170
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.